AI Analysis
Log in to generate an AI summary for this stock.
Log in to generate a MOAT report for this stock.
Log in to generate an earnings report for this stock.
Log in to generate an operating leverage report for this stock.
Log in to generate a management report for this stock.
Log in to generate a valuation report for this stock.
Rafael Holdings, Inc.
Video analysis: RFL
All videosNo video analysis for this stock yet. Request one from our team.
News: RFL
Nuclea Energy USA Inc. Announces MOU with Utah Office of Energy Development
The MOU supports exploration of a nuclear test reactor site at the Utah San Rafael Energy Lab to advance the Morpheus microreactor toward demonstration and deployment Salt Lake City, Utah--(Newsfile Corp. - August 5, 2026) - Nuclea Energy USA Inc. ("Nuclea USA"), a wholly owned subsidiary of Nuclea Energy Inc. ("Nuclea"), an advanced nuclear technology developer, is pleased to publicly announce the signing of a memorandum of understanding (MOU) on June 2, 2026 with the State of Utah Office of Energy Development ("OED") to explore the siting of a nuclear test reactor at the Utah San Rafael Energy Lab ("USREL") to advance the deployment of Nuclea's Morpheus Micro Reactor. The MOU marks an important step in advancing research, development and commercial deployment of Nuclea's micro modular reactor.
Head to Head Comparison: Oncology Pharma (OTCMKTS:ONPH) & Rafael (NYSE:RFL)
Rafael (NYSE: RFL - Get Free Report) and Oncology Pharma (OTCMKTS:ONPH - Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, earnings, profitability and institutional ownership. Earnings and Valuation This table compares Rafael and
Manhattan Uranium Identifies High-Grade Uranium Intercepts from 5,668-Hole Database Compilation at I-70, San Rafael District, Utah
72% of Drilled Holes Return Uranium Mineralization; 3D Drill Targets Generated Across Historical Utah Uranium District Vancouver, British Columbia--(Newsfile Corp. - July 23, 2026) - Manhattan Uranium Discovery Corp. (TSXV: MANU) (OTC Pink: MAUUF) (FSE: JB50) ("Manhattan" or the "Company") is pleased to provide an update on ongoing technical work at its I-70 uranium project (the "I-70 Project" or "I-70"), located in the San Rafael uranium district of Utah. The Company has completed a major historical data compilation and digitization effort focused on building a modern drillhole and geological database for the I-70 Project.
Sekur Private Data Appoints Special Operations Communications Chief Master Sergeant (Ret.) Rafael Beltran to Its OpsTech Special Advisory Board
Former SOCOM Senior Technical Advisor to CIO/J6 and Executive Communications Chief to Guide Sekur's Tactical Technology Strategy for Defense, Intelligence and Government Markets MIAMI, FL / ACCESS Newswire / July 7, 2026 / Sekur Private Data, Inc. , a Miami-based leading Swiss-hosted cybersecurity, private communications, and defense communications company serving enterprise, government, and defense clients, and wholly owned U.S.-based subsidiary of Sekur Private Data ( OTCQB:SWISF )(CSE:SKUR)(FRA:GDT0) ("Sekur" or the "Company"), is pleased to announce the appointment of Rafael Beltran to its Special Advisory Board - OpsTech . Beltran brings more than a decade of U.S. Special Operations communications leadership, including senior technical advisory roles at the Headquarters, U.S. Special Operations Command (SOCOM) , to help guide the Company's tactical technology strategy across defense, intelligence, and government markets.
AuMEGA Metals Appoints Rafael Gradim as President
Highly accomplished executive with extensive exploration, strategy, corporate development and capital markets experience to lead exploration Edmonton, Alberta--(Newsfile Corp. - July 6, 2026) - AuMEGA Metals Ltd. (ASX: AAM) (TSXV: AUM) (OTCQB: AUMMF) ("AuMEGA" or "the Company") announces that Michael Skead will step down as President of the Company, effective immediately, for personal reasons.
Rafael Holdings: The Second Half Of Calendar 2026 Could Define This Company Forever
Rafael Holdings' Phase 3 clinical trial of a drug named Trappsol Cyclo just got over. Results of the trial are expected in the second half of 2026. RFL has a runway of 4 to 5 quarters. RFL could end up borrowing money in the event of trial results getting delayed or FDA approval getting stretched. In my opinion, RFL does present a compelling investment case for risk-appetite investors. Conservative investors should wait until the trial results are out.
Heineken names Rafael Oliveira as CEO
Dutch beer maker Heineken has appointed Rafael Oliveira as its new chair and CEO, it said on Tuesday, becoming one of several alcoholic drinks makers to seek to galvanise sales through a change of leadership.
Heineken N.V. announces nomination of Rafael Oliveira as Chief Executive Officer
Amsterdam, 23 June 2026 Heineken N.V. announces nomination of Rafael Oliveira as Chief Executive Officer The Supervisory Board of Heineken N.V.
Similar companies
-
Fathom Holdings Inc.
FTHM
·
NASDAQ
Compare
-
Sachem Capital Corp.
SACH
·
New York Stock Exchange Arca
Compare
-
Ohmyhome Limited
OMH
·
NASDAQ
Compare
-
Ashford Hospitality Trust, Inc.
AHT
·
New York Stock Exchange
Compare
-
Token Communities Ltd.
TKCM
·
Other OTC
Compare
-
Offerpad Solutions Inc.
OPAD
·
NASDAQ
Compare